{"id":"W2104818454","doi":"10.1016/s1474-4422(14)70251-0","title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":3882,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University","funders":"Merck Sharp and Dohme; U.S. Food and Drug Administration; National Institutes of Health; Innovative Medicines Initiative; Medtronic; Bayer Schering; Advanced Scientific Computing Research; Eisai; Bundesministerium für Bildung und Forschung; National Centre for the Replacement Refinement and Reduction of Animals in Research; National Institute of Neurological Disorders and Stroke; National Centre for the Replacement, Refinement and Reduction of Animals in Research; National Institute of Academic Anaesthesia; Boehringer Ingelheim; Novartis; Biogen Idec; AbbVie; Deutsche Forschungsgemeinschaft; Merck; Dunhill Medical Trust; Wellcome Trust; Sanofi Pasteur; Astellas Pharma US; Westminster Medical School Research Trust; Pfizer; International Fibrodysplasia Ossificans Progressiva Association; Allergan; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Pharmacotherapy; Neuropathic pain; Medicine; Meta-analysis; Anesthesia; Psychiatry; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}